Search Results - Lorenza Di Guardo

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience

    Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience by Alice Indini, Lorenza Di Guardo, Carolina Cimminiello, Domenica Lorusso, Francesco Raspagliesi, Michele Del Vecchio

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Bevacizumab plus Fotemustine as First-line Treatment in Metastatic Melanoma Patients: Clinical Activity and Modulation of Angiogenesis and Lymphangiogenesis Factors

    Bevacizumab plus Fotemustine as First-line Treatment in Metastatic Melanoma Patients: Clinical Activity and Modulation of Angiogenesis and Lymphangiogenesis Factors by Michele Del Vecchio, Roberta Mortarini, Stefania Canova, Lorenza Di Guardo, Nicola Pimpinelli, M. R. Sertoli, Davide Bedognetti, Paola Queirolo, Paola Morosini, Tania Perrone, Emilio Bajetta, Andrea Anichini

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Current status and perspectives in immunotherapy for metastatic melanoma

    Current status and perspectives in immunotherapy for metastatic melanoma by Riccardo Marconcini, Francesco Spagnolo, Luigia Stefania Stucci, Simone Ribero, Elena Marra, Francesco De Rosa, Virginia Picasso, Lorenza Di Guardo, Carolina Cimminiello, Stefano Cavalieri, L. Orgiano, Enrica T. Tanda, Laura Spano�, Alfredo Falcone, Paola Queirolo

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy

    Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy by Vanna Chiarion‐Sileni, Jacopo Pigozzo, Paolo A. Ascierto, Ester Simeone, Michele Maio, Luana Calabrò, Paolo Marchetti, Federica De Galitiis, Alessandro Testori, Pier Francesco Ferrucci, Paola Queirolo, Francesco Spagnolo, Pietro Quaglino, Fabrizio Carnevale Schianca, Mario Mandalà, Lorenza Di Guardo, Michele Del Vecchio

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study

    Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study by Luis de la Cruz‐Merino, Lorenza Di Guardo, Jean‐Jacques Grob, Alfredo Venosa, James Larkin, Grant A. McArthur, Antoni Ribas, Paolo A. Ascierto, Jeffrey Evans, Antonio Gómez-Escobar, Giulio Barteselli, Susan Eng, Jessie J. Hsu, Anne Uyei, Brigitte Dréno

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study

    Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study by Piotr Rutkowski, Alice Indini, Matilde De Luca, Barbara Merelli, Anna Mariuk-Jarema, Paweł Teterycz, Paweł Rogala, Iwona Ługowska, Bożena Cybulska-Stopa, Alice Labianca, Lorenza Di Guardo, Michele Del Vecchio, Jacopo Pigozzo, Giovanni Randon, Francesca Corti, Carlo Tondini, Eliana Rulli, Mario Mandalà

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

    Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases by Paola Queirolo, Francesco Spagnolo, Paolo A. Ascierto, Ester Simeone, Paolo Marchetti, Alessandro Scoppola, Michele Del Vecchio, Lorenza Di Guardo, Michele Maio, Anna Maria Di Giacomo, Andrea Antonuzzo, Francesco Cognetti, Virginia Ferraresi, Laura Ridolfi, Massimo Guidoboni, Michele Guida, Jacopo Pigozzo, Vanna Chiarion‐Sileni

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

    Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma by Michele Del Vecchio, Lorenza Di Guardo, Paolo A. Ascierto, Antonio M. Grimaldi, Vanna Chiarion‐Sileni, Jacopo Pigozzo, Virginia Ferraresi, Carmen Nuzzo, Gaetana Rinaldi, Alessandro Testori, Pier Francesco Ferrucci, Paolo Marchetti, Federica De Galitiis, Paola Queirolo, Elena Tornari, Riccardo Marconcini, Luana Calabrò, Michele Maio

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

    Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort by Paolo A. Ascierto, Ester Simeone, Vanna Chiarion‐Sileni, Jacopo Pigozzo, Michele Maio, Maresa Altomonte, Michele Del Vecchio, Lorenza Di Guardo, Paolo Marchetti, Ruggero Ridolfi, Francesco Cognetti, Alessandro Testori, Maria Grazia Bernengo, Michele Guida, Riccardo Marconcini, Mario Mandalà, Carolina Cimminiello, Gaetana Rinaldi, Massimo Aglietta, Paola Queirolo

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b

    Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b by Elisabetta Vergani, Lorenza Di Guardo, Matteo Dugo, Sara Rigoletto, Gabrina Tragni, Roberta Ruggeri, Federica Perrone, Elena Tamborini, Annunziata Gloghini, Flavio Arienti, Barbara Vergani, Paola Deho, Loris De Cecco, Viviana Vallacchi, Paola Frati, Eriomina Shahaj, Antonello Villa, Mario Santinami, Filippo de Braud, Licia Rivoltini, Monica Rodolfo

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme

    Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme by Vanna Chiarion‐Sileni, Jacopo Pigozzo, Paolo A. Ascierto, Antonio M. Grimaldi, Michele Maio, Lorenza Di Guardo, Paolo Marchetti, Francesco De Rosa, Carmen Nuzzo, Alessandro Testori, Emilia Cocorocchio, Maria Grazia Bernengo, Michele Guida, Riccardo Marconcini, Barbara Merelli, Giorgio Parmiani, Gaetana Rinaldi, Massimo Aglietta, Marco Grosso, Paola Queirolo

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma

    Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma by Veronica Huber, Viviana Vallacchi, Viktor Fleming, Xiaoying Hu, Agata Cova, Matteo Dugo, Eriomina Shahaj, Roberta Sulsenti, Elisabetta Vergani, Paola Filipazzi, Angela De Laurentiis, Luca Lalli, Lorenza Di Guardo, Roberto Patuzzo, Barbara Vergani, Elena Casiraghi, Mara Cossa, Ambra V. Gualeni, Valentina Bollati, Flavio Arienti, Filippo de Braud, Luigi Mariani, Antonello Villa, Peter Altevogt, Viktor Umansky, Monica Rodolfo, Licia Rivoltini

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors

    The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors by Daniela Massi, Eliana Rulli, Mara Cossa, Barbara Valeri, Monica Rodolfo, Barbara Merelli, Francesco De Logu, Romina Nassini, Michele Del Vecchio, Lorenza Di Guardo, Roberta De Penni, Michele Guida, Vanna Chiarion‐Sileni, Anna Maria Di Giacomo, Marco Tucci, Marcella Occelli, Francesca Portelli, Viviana Vallacchi, Francesca Consoli, Pietro Quaglino, Paola Queirolo, Gianna Baroni, Fabrizio Carnevale‐Schianca, Laura Cattaneo, Alessandro Marco Minisini, Giuseppe Palmieri, Licia Rivoltini, Mario Mandalà

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: